New treatment option for metastatic colorectal cancer prolongs survival

1 Views

07/07/23

#colorectalcancer #treatment #FRESCO-2

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.
Results from an international clinical trial, published June 15 in The Lancet, show that the selective targeted therapy, Fruquintinib, resulted in a statistically significant improvement in overall survival and
progression-free survival.

Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: https://twitter.com/medicaldialogs
Facebook: https://www.facebook.com/medicaldialogues/
Instagram: https://www.instagram.com/medicaldialogues
LinkedIn: https://www.linkedin.com/company/medical-dialogues
Website: https://medicaldialogues.in/